Palisade bio announces 1-for-15 reverse stock split

Carlsbad, ca, april 03, 2024 (globe newswire) -- palisade bio, inc. (nasdaq: pali), (“palisade”, “palisade bio” or the “company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced a 1-for-15 reverse split of its common stock, par value $0.01 (“common stock”), effective at 5:00 pm et on friday april 5, 2024. beginning on monday, april 8, 2024, the company's common stock will continue to trade on the nasdaq capital market (“nasdaq”) on a split adjusted basis under the trading symbol “pali,” but will trade under the following new cusip number starting april 8, 2024: 696389402.
PALI Ratings Summary
PALI Quant Ranking